chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Slight fever.  Trembling. Nauseous.  Eventually vomited.  Symptoms last appox 20 hours.
Fever, chills, muscle aches beginning at 1:00 a.m.  Acetaminophen taken at 3:00 a.m. Fever and chills controlled at 4:00 a.m.
Mobility decreased; Vaccination site pain; very sleepy; headache; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (very sleepy), MOBILITY DECREASED (Mobility decreased), HEADACHE (headache) and VACCINATION SITE PAIN (Vaccination site pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD (worsened after shot given) since August 2010, Chronic bronchitis (have more incidenses) since 1966, Drug allergy (Allergic to steroids), Depression, Acid reflux (esophageal), Heart disorder (unspecified) and Bone disorder. Concomitant products included FAMOTIDINE for Acid reflux (esophageal), CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]) for Bone disorder (NOS), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and DULOXETINE HYDROCHLORIDE (CYMBALTA) for Depression, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Heart disorder.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced SOMNOLENCE (very sleepy) and HEADACHE (headache). On 24-Apr-2021, the patient experienced MOBILITY DECREASED (Mobility decreased) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, SOMNOLENCE (very sleepy), MOBILITY DECREASED (Mobility decreased), HEADACHE (headache) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment information  was provided.   This case was linked to MOD-2021-187185 (Patient Link).
Principal Diagnoses:  Principal Problem:   Acute pulmonary embolism without acute cor pulmonale     Discharge Diagnosis:  RLL PE, Recent COVID 19, Dm2,    Hospital Course:  The patient was admitted with the above. He was on room air. He did not have an elevation in troponin. He did not have RV strain on CTA of the chest. He was placed on an elequis starter pack and asked to follow up outpatient. His blood sugars here were in the 300's. He was placed on metformin and asked to follow up outpatient.
breakout in March2021/suspected vaccination failure; breakout in March2021; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (In the past 20 years the patient had a shingles breakout each year and had been anxiously awaiting the vaccine).   On 25th February 2021, the patient received the 2nd dose of Shingrix. On an unknown date, the patient received the 1st dose of Shingrix. In March 2021, less than 2 months after receiving Shingrix and unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.   Additional details were reported as follows: The case was reported by the patient. The patient had 2nd Shingrix vaccination and had a breakout in March of 2021.  Permission denied for follow up. This case was considered as suspected vaccination failure as time to onset and laboratory confirmation for shingles were unknown at the time of reporting. This was 1 of 3 cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR203694:Same patient, 2nd dose and breakout March2021
Tinnitus and minor hearing loss in right ear, on and off, for last 2 days. No treatment taken so far.
I started having full body aches and pins and needles sensation down to my toes. My skin has also felt hypersensitive. I also had bad chills, a headache, and stomach pains, and it lasted through the night so I slept horribly. I?m still not feeling well but I?m better today.
Rash; Shooting pain in neck; Room is spinning looks like I amriding a merry go round; Dizzy; Light headed; Low heart rate followed by spurts of quick, off rhythm beats; Numbness in arms and hands; This is a spontaneous report from a contactable healthcare professional, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM8731) via an unspecified route of administration in the left arm on 06May2021 at 11:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease and allergic to penicillin allergy, gluten, chocolate and tree nuts. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 07May2021 at 16:30, the patient experienced rash, shooting pain in neck, room was spinning- looks like the patient was riding a merry go round, dizzy, light headed, low heart rate followed by spurts of quick, off rhythm beats and numbness in arms and hands. On 07May2021, the patient underwent heart rate rest and the result was decreased heart rate. The events did not result in doctor or other healthcare professional office, clinic visit, emergency room, department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash, shooting pain in neck, room was spinning- looks like the patient was riding a merry go round, dizzy, light headed, low heart rate followed by spurts of quick, off rhythm beats and numbness in arms and hands was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
pt states recvd vax 12OCT95 & that afternoon arm was sore, Friday had chills, fever & had emesis; Saturday still some pain @ the site under armpits to point unable to move very well;inj site was inflamed & reddened to the shoulder
Moderna dose 1 given on 3/10/21 and patient subsequently admitted to the hospital on 3/31/21 with COVID-19
4PM 5FEB93 warm, pt was moaning; 1AM 6FEB93 t105 R;
Decrease in milk supply for 24 hours. Went from producing 18oz a day to only making 5oz. Patient doubled water intake the day before, during, and after.
Patient was flushed in appearance and said she felt dizzy/faint and eventually vomitted.  She was provided applesauce.
Severe local reactions approx 72 hrs p/receiving the vax; c/o swelling, pain, hot to the touch; These reactions were more severe than previous immun;
NON-STOP SLEEPING; LAZINESS; SWOLLEN LEFT ARM; SORENESS IN LEFT ARM; This spontaneous report received from a patient concerned a 53 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced non-stop sleeping. On APR-2021, the subject experienced laziness. On APR-2021, the subject experienced swollen left arm. On APR-2021, the subject experienced soreness in left arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from non-stop sleeping, soreness in left arm, laziness, and swollen left arm. This report was non-serious.
This spontaneous report was received from a registered nurse concerning an unspecified number of unspecified patients who on unknown dates might have received improperly stored dose of and COMVAX (dose, route and lot # not provided). No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected.
Sore throat; Sinus pain; Body aches and pain; Stomach cramping; Diarrhoea; Extreme fatigue; Headache; Swollen lymph nodes in throat; Sinus drainage; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via unspecified route of administration in left arm on 17Mar2021 at 10:15 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. On 19Mar2021 at 07:00, the patient experienced sore throat, sinus pain, drainage, swollen lymph nodes in throat, headache, body aches and pain, stomach cramping, diarrhoea and extreme fatigue. It was reported that the patient did not receive any treatment for the reported events. The clinical outcome of sore throat, sinus pain, drainage, swollen lymph nodes in throat, headache, body aches and pain, stomach cramping, diarrhoea and extreme fatigue were not resolved.   No follow-up attempts are needed. No further information is expected.
Seizure Generalized tonic clinic 1.5 minutes.   EEG and MRI negative.  no treatment needed.
pt inconsolable crying x 1 hr apparent discomfort when legs moved; legs swollen; blotchy; no fever; exam as above intermittently consolable if swaddled; sl induration inc warmth bilat thighs, blotchy macular blanching discoloration;
Irregular heart beat, headaches, tiredness, swollen throat, shortness of breath, dizziness, left leg goes to sleep often. The symptoms appear to be slowly improving, but it's been 3 weeks. For the first 4-5 days the left hand drawed/cramped inhibiting control, and right elbow would lock up inhibiting ability to bend arm. But those side effects are barely noticeable now. Also my throat was badly swollen but slowly getting better. I almost never take any type of medication including prescription and OTC drugs. I almost never go to the doctor, and do not currently have a family doctor. Can a doctor do anything to fix this for me? Is there an antidote or something I can take? Perhaps a process in place to undo this?
Left upper arm with erythema and swelling extending from shoulder to elbow. No systemic reaction.
Sore throat; Fever; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 15Apr2021 at 07:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included coronary artery disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 20Apr2021 at 12:30, the patient experienced sore throat, fever and exhaustion. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, fever and exhaustion was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Got vaccine, had severe case of shingles/Suspected vaccination failure; severe shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 7-Oct-2022 Reporter's comment: The case was received from the patient's friend via  interactive digital media. The patient's friend reported that the patient never had shingles but after getting the shingles vaccination, had sever case of the shingles. The case was linked with case US2022AMR144790 reported by same reporter for different patient. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR144790:Same reporter US-GSK-US2022AMR132558:Same reporter
Sore arm , Extreme fatigue 4/29/21 On 4/30/21- extreme trembling - lasting nearly 25 minutes / numb fingers and toes / headache
Assessment and Plan Patient is a 77 y.o. female patient with history of COPD, IDDM. presented to Hospital with Hypoxia and multifocal covid 19 pneumonia     Covid-19 Virus Infection Date of onset of symptoms: 1/21/23 Symptoms present on admission: yes Date of covid positive test: 1/22/23 Vaccination status: vaccinated Imaging: Ct chest Oxygen requirements on admission: 2l Current oxygen requirements: 2l Medical therapy: remdesivir (given 2 doses prior to discharge) Consultants following: None Anticipated special isolation end date: TBD   Acute on chronic hypoxic respiratory failure,  Covid 19 pneumonia with hypoxia CT chest shows multifocal pneumonia without PE Start Remdesivir  IV decadron x1 in ED, with no significant hypoxia or increased work of breathing, will avoid administration of additional steroids at this time Nasal oxygen to keep saturation above 92% Patient wears 3 L nasal cannula at night at home, and states that she has been consistently wearing this during the day over the last several months Continue bronchodilator inhalers Ambulatory home oxygen evaluation showed desaturation at lowest point to 89% with rapid recovery on room air to 93%, therefore does not qualify for home oxygen around-the-clock at this time Given improvement in symptoms, patient stable for discharge Recommend PCP follow-up in approximately 1 to 2 weeks   Uncontrolled insulin-dependent type 2 diabetes mellitus with hyperglycemia On Lantus 35 unit BID, high-dose/resistant sliding scale coverage added while inpatient Likely secondary to previous administration of Decadron in emergency department Have changed patient's diet to diabetic, and did have regular diet this morning prior to change of diet Blood glucose levels improved at time of discharge   COPD  Albuterol Advair inhaler   Hypokalemia (resolved) Mild, potassium 3.4 on admission KCL po ordered Potassium 3.8 (1/24)   Essential hypertension Continue metoprolol, Aldactone
pt recvd vax & 2mins post vax exp syncope w/minor sz activity;felt intense pain in arm, then blacked out;hands clenched & curled, fell to the floor (exp a chin abrasion from striking the carpet);pt unresponsive;hypotensive, finger swelled
After receiving vaccination, patient stated she felt dizzy. I sat her down in the designated Covid chairs and advised that she wait here for 30 minutes, I got her a water and a cool towel.  After the 30 minutes she said she had a headache and still felt dizzy so I gave her 25mg of benedryl liquid. After about 10 minutes she said she was feeling better and was going home.
Friends noticed rash above bilateral eyebrows, L cheek.  Rash observed by PHN above eyes bilaterally.  No urticaria, no hives, no rash/reaction at injection sites.  Headache began 10pm on 2/12/08 continuing through 2/13/08 when seen by PHN.
pt recvd vax;that noc, devel high fever & lt arm & underarm from elbow up as well as chest were swollen & red;site of inject no longer discernible;had pain throughout the entire area;sxs worsened by am;f/u:md has no further contact w/ pt
All 3 vaccines were given at 10:15am, patient released from waiting room with mother at 10:30am. about 11am staff reported mother came back to clinic and knocked on the door to the department, pt noted to have hives on both lower forearms. No shortness of breath noted. MD called to room to check on patient and order received to given Benadryl 14mls which was given at 11:09am. Mother and patient kept in exam room back to pediatrics for close monitoring for about 1 hours.  Rash was gone by the time mother and patient was released from the clinic and mother reported no problems noted once home.
Swelling of the feet, ankles, wrist. Joint discomfort, weakness, loss of appetite all around achy on and off fever, cough.
Redness & swelling at injection site of ADACEL vaccine. Client states Dr gave her an antibiotic for reaction.
My left upper arm became extremely painful to move and to the touch. I developed a red, circular, hard, hot, raised welt at the injection site the size of an inch. It took 2 weeks to completely resolve. It slowly got bigger to the size of the palm of my hand, but got less angry looking and not as painful. Heat and one dose of ibuprofen helped.
missed the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed the 2nd dose) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed the 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed the 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient missed her 2nd dose which was scheduled on 11-May-2021.  Concomitant medication not provided.  Treatment information not provided.
ROTATEQ, PEDV AX HIB, RECOMBIV AX HB, GARDASIL 9 and VAQTA that went out of range were potentially administered; No additional adverse effect reported; Information has been received from a nurse istant and refers to a patient of unknown age and gender. There was no information about patient's concurrent conditions, medical history, concomitant medications or drug reactions/allergies.  On unknown dates, the patient was potentially vaccinated with doses of the following vaccines that were out of range: hepatitis b vaccine (recombinant)(RECOMBIVAX HB), lot # R028529 and expiration date of 09-JUN-2021, lot # T004378 and expiration date of 01-NOV-2022 and lot # R021372 and expiration date of 25-MAY-2021, hepatitis a vaccine, inactivated(VAQTA) lot # T020442 and expiration date of 26-JAN-2022 and lot # T014835 and expiration date of 17-JUL-2021, haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) lot # T001208 and expiration date of 09-JUN-2022 and lot # T020615 and expiration date of 13-MAR-2023, hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot number 1621926 and expiration date of 28-NOV-2021 and lot # 1602284 and expiration date of 26-SEP-2021 (route of administration and anatomical location were not reported) and with rotavirus vaccine, live, oral, pentavalent(ROTATEQ) lot # 1676322 and expiration date of 21-APR-2021, lot # 1688822 and expiration date of 20-NOV-2021 and lot # 1691301 and expiration date of 12-DEC-2021 per oral route, all for prophylaxis, which were stored in the following ranges: 9 Celsius degrees to 25 Celsius degrees (8.53 Celsius degrees) for 15 minutes and 9 Celsius degrees to 25 Celsius degrees (11.6 Celsius degrees) for 45 minutes.  No previous temperature excursion was reported. No additional adverse effects were reported.  Digital data logger was involved.  This is one of several reports from the same reporter. ; Sender's Comments:  US-009507513-2103USA003717: US-009507513-2103USA005236: US-009507513-2103USA005237: US-009507513-2103USA005238: US-009507513-2103USA005239: US-009507513-2103USA005240: US-009507513-2103USA005241: US-009507513-2103USA005233: US-009507513-2103USA005235:
Gout on left toe, hard to read and reaction; Gout on left toe, hard to read and reaction; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2020US275133.  A 80 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 80 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GOUT (non-serious), READING DISORDER (non-serious), outcome "unknown" and all described as "Gout on left toe, hard to read and reaction".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Nausea, headache, body ache, fatigue, fever up to 102.5 degrees F
About two months after I took both the first vaccine of Covid and the booster shot, I start experiencing Hypersalivation where my glands producing salivae have been producing saliva in excess and my mouth will be filled with salivae to the point I need to constantly spit ...
CG left vaccine clinic after 30 minutes and went to the bathroom, while sitting on the toilet she felt faint, ringing in her ears, numbness in legs, & dizzy. She immediately went to the ER at Petaluma Valley Hospital since she was still on campus. She received some medications (Benadryl, Tylenol & Toradol from which she had N/V at home. She called out sick the next day with body aches and pains and resumed work the following day.
I got my booster shot from Hospital. The same night I was using bathroom and I collapsed and was unconscious. While I collapsed unconsciously i hit my head with the shower door handle and my neck got hurt due to the collapsing on the floor.   The same thing happened next morning and this time my wife witnessed me laying on the ground unconsciously and my body was shaking as per my wife.   I went to ER to get help,  but they did some tests and told me that everything was fine. I wanted to get myself checked thoroughly through my Primary Care physician. I didn't get an appointment with her but was put on the phone call with a Nurse Practitioner. She was rude and not dealt with me fairly. To my shock she was like "this kind of reaction to booster is normal". I mean how many people collapsed and were unconscious after taking booster? This isn't a normal reaction. She was discouraging me from taking further medical checkups to rule out blood clot or any issue with my brain and my neck pain.   She was not doing her job property and was not professional in the way she was suppose to be. I repeatedly said to her that I want to make sure I don't have any other serious internal health issue due to the booster since I had twice the episode of the collapsing and shaken body.